XML 44 R34.htm IDEA: XBRL DOCUMENT v3.23.1
Equity Investments (Tables)
9 Months Ended
Apr. 30, 2023
Investments, Debt and Equity Securities [Abstract]  
Schedule of Equity Investments

Equity investments consist of the following:

 

  

April 30,

2023

  

July 31,

2022

 
   (in thousands) 
Zedge, Inc. Class B common stock, 42,282 shares at April 30, 2023 and July 31, 2022  $84   $117 
Zedge, Inc. Class B common stock, 42,282 shares at April 30, 2023 and July 31, 2022  $84   $117 
Rafael Holdings, Inc. Class B common stock, 278,810 and 290,214 shares at April 30, 2023 and July 31, 2022, respectively   586    586 
Other marketable equity securities   1,112    4,089 
Fixed income mutual funds   3,994    12,299 
           
Current equity investments  $5,776   $17,091 
           
Visa Inc. Series C Convertible Participating Preferred Stock (“Visa Series C Preferred”)  $1,238   $1,132 
Visa Inc. Series A Convertible Participating Preferred Stock (“Visa Series A Preferred”)       1,230 
Convertible preferred stock—equity method investment   3,064    1,001 
Hedge funds   3,136    3,238 
Other   2,825    825 
Noncurrent equity investments  $10,263   $7,426 
Schedule of Carrying Value of Equity Investments

The changes in the carrying value of the Company’s equity investments without readily determinable fair values for which the Company elected the measurement alternative was as follows:

 

  

2023

  

2022

  

2023

  

2022

 
   Three Months Ended
April 30,

Nine Months Ended

April 30,

 
  

2023

  

2022

  

2023

  

2022

 
   (in thousands) 
Balance, beginning of period  $1,494   $2,539   $1,401   $2,743 
Adjustment for observable transactions involving a similar investment from the same issuer   13    (130)   106    (334)
Impairments                
                     
Balance, end of the period  $1,507   $2,409   $1,507   $2,409 

Schedule of Unrealized (losses) Gains for All Equity Investments

Unrealized gains and losses for all equity investments measured at fair value included the following:

 

  

2023

  

2022

  

2023

  

2022

 
   Three Months Ended
April 30,
  

Nine Months Ended

April 30,

 
  

2023

  

2022

  

2023

  

2022

 
   (in thousands) 
Net losses recognized during the period on equity investments  $(480)  $(3,416)  $(2,649)  $(20,862)
Less: net gains recognized during the period on equity investments sold during the period           18    10 
Unrealized losses recognized during the period on equity investments still held at the reporting date  $(480)  $(3,416)  $(2,667)  $(20,872)

 

The unrealized gains and losses for all equity investments measured at fair value in the table above included the following:

 

  

2023

  

2022

  

2023

  

2022

 
  

Three Months Ended

April 30,

  

Nine Months Ended

April 30,

 
  

2023

  

2022

  

2023

  

2022

 
   (in thousands) 
Unrealized gains (losses) recognized during the period on equity investments:                    
Rafael Class B common stock  $11   $(578)  $20   $(14,064)
                     
Zedge Class B common stock  $(9)  $(102)  $(33)  $(432)
Summary of Changes in Equity Method Investments

The following table summarizes the change in the balance of the Company’s equity method investment:

 

   2023   2022   2023   2022 
  

Three Months Ended

April 30,

  

Nine Months Ended

April 30,

 
   2023   2022   2023   2022 
    (in thousands) 
Balance, beginning of period  $(374)  $2,509   $1,001   $2,901 
Purchase of convertible preferred stock   168        168    1,051 
Conversion of secured promissory notes into convertible preferred stock   4,038        4,038     
Equity in the net loss of investee   (532)   (583)   (1,544)   (1,662)
Amortization of equity method basis difference   (236)   (182)   (599)   (546)
                     
Balance, end of the period  $3,064   $1,744   $3,064   $1,744 

Summary of Statements of Operations

Summarized financial information of the EMI was as follows:

  

   2023   2022   2023   2022 
  

Three Months Ended

April 30,

  

Nine Months Ended

April 30,

 
   2023   2022   2023   2022 
   (in thousands) 
                 
Revenues  $2,115   $2,689   $5,806   $5,760 
Costs and expenses:                    
Direct cost of revenues   1,693    4,402    4,921    7,307 
Selling, general and administrative   2,080    1,265    5,488    3,928 
                     
Total costs and expenses   3,773    5,667    10,409    11,235 
                     
Loss from operations   (1,658)   (2,978)   (4,603)   (5,475)
Other expense   (266)   (82)   (1,108)   (83)
                     
Net loss  $(1,924)  $(3,060)  $(5,711)  $(5,558)